President & CEO of Sage Therapeutics Inc (SAGE, Financial) Jeffrey M Jonas sold 94,264 shares of SAGE on 05/24/2019 at an average price of $174.75 a share. The total sale was $16.5 million.
Sage Therapeutics Inc is a biopharmaceutical company conducting development programs and clinical trials to discover medicines for central nervous system disorders. It has development programs for refractory status epilepticus, and Parkinson's di-sease. Sage Therapeutics Inc has a market cap of $8.97 billion; its shares were traded at around $175.39 with and P/S ratio of 89.95.
CEO Recent Trades:
- President & CEO Jeffrey M Jonas sold 94,264 shares of SAGE stock on 05/24/2019 at the average price of $174.75. The price of the stock has increased by 0.37% since.
Directors and Officers Recent Trades:
- Chief Business Officer Michael Cloonan sold 25,000 shares of SAGE stock on 05/22/2019 at the average price of $175. The price of the stock has increased by 0.22% since.
- SVP, GC & Secretary Anne Marie Cook sold 15,000 shares of SAGE stock on 05/10/2019 at the average price of $166.14. The price of the stock has increased by 5.57% since.
- Director James M Frates sold 8,000 shares of SAGE stock on 05/06/2019 at the average price of $162.22. The price of the stock has increased by 8.12% since.
For the complete insider trading history of SAGE, click here
.
